Silicon Laboratories (NASDAQ:SLAB – Get Free Report) had its price objective decreased by equities researchers at Stifel Nicolaus from $145.00 to $120.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the semiconductor company’s stock. Stifel Nicolaus’ price objective would indicate a potential upside of 33.89% from the stock’s previous close.
A number of other equities research analysts have also issued reports on the company. Barclays increased their target price on Silicon Laboratories from $75.00 to $120.00 and gave the company an “equal weight” rating in a research note on Friday, January 17th. KeyCorp lifted their target price on Silicon Laboratories from $115.00 to $160.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 22nd. Benchmark reiterated a “buy” rating and set a $160.00 price objective on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Needham & Company LLC reiterated a “buy” rating and issued a $150.00 target price on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Finally, StockNews.com cut Silicon Laboratories from a “hold” rating to a “sell” rating in a report on Thursday, March 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $133.70.
View Our Latest Analysis on SLAB
Silicon Laboratories Stock Performance
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). The company had revenue of $166.25 million during the quarter, compared to analysts’ expectations of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business’s quarterly revenue was up 91.4% compared to the same quarter last year. During the same period in the previous year, the company earned ($1.19) EPS. On average, research analysts anticipate that Silicon Laboratories will post -0.97 EPS for the current fiscal year.
Insider Transactions at Silicon Laboratories
In other news, Director William G. Bock sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of $140.77, for a total transaction of $281,540.00. Following the sale, the director now owns 32,115 shares in the company, valued at $4,520,828.55. The trade was a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Navdeep S. Sooch sold 2,360 shares of the firm’s stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the transaction, the director now directly owns 400,567 shares of the company’s stock, valued at $59,684,483. This represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,360 shares of company stock valued at $782,610 over the last three months. Company insiders own 1.60% of the company’s stock.
Institutional Trading of Silicon Laboratories
A number of hedge funds have recently made changes to their positions in SLAB. Coldstream Capital Management Inc. increased its stake in Silicon Laboratories by 2.8% in the 4th quarter. Coldstream Capital Management Inc. now owns 2,473 shares of the semiconductor company’s stock valued at $307,000 after buying an additional 68 shares during the period. Jones Financial Companies Lllp boosted its position in Silicon Laboratories by 44.5% during the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock valued at $28,000 after purchasing an additional 69 shares during the last quarter. Pacer Advisors Inc. grew its stake in Silicon Laboratories by 1.8% in the fourth quarter. Pacer Advisors Inc. now owns 4,839 shares of the semiconductor company’s stock valued at $601,000 after purchasing an additional 87 shares in the last quarter. Louisiana State Employees Retirement System grew its stake in shares of Silicon Laboratories by 1.1% in the 4th quarter. Louisiana State Employees Retirement System now owns 9,000 shares of the semiconductor company’s stock valued at $1,118,000 after buying an additional 100 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its holdings in Silicon Laboratories by 1.4% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 7,169 shares of the semiconductor company’s stock worth $891,000 after buying an additional 102 shares during the last quarter.
About Silicon Laboratories
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Recommended Stories
- Five stocks we like better than Silicon Laboratories
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
- Buy P&G Now, Before It Sets A New All-Time High
- Rocket Lab’s Growth Potential Gains Altitude on Defense News
- Using the MarketBeat Dividend Yield Calculator
- Goldman Sachs Just Revealed What’s Next for Markets
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.